Antibody Drug Treatments
-
{
- All
- News
-
Can Antibodies From Camels Help Develop Dengue Vaccines? Researchers From Mohali Reveal
Researchers from Indian Institute of Science Education and Research (IISER) Mohali have discovered that unique antibodies from camels may help neutralise the dengue virus. Scientists say these tiny "nanobodies" could pave the way for future dengue tr
-
Top Scientific Discoveries Of 2025: A Year of Quantum Leaps And Cosmic Revelations
Here's a look at scientific discoveries and breakthroughs that made headlines in 2025, spanning space, biology, ecology, and fundamental physics.
-
2 New Medicines For Covid Treatment Get WHO Approval
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
-
Delhi's LNJP Hospital Begins Free Antibody Cocktail Therapy For Covid Patients
The Monoclonal Antibody Cocktail used to treat mild to moderate "high risk" Covid patients is now available at Delhi's Lok Nayak Jai Prakash Narayan Hospital (LNJP) for free.
-
Antibody Cocktail Used In Covid Treatment Gets Emergency Use Approval
Drug firm Roche India on Wednesday said it has received Emergency Use Authorisation (EUA) from the Central Drugs Standards Control Organisation (CDSCO) for Roche's investigational antibody cocktail used in the treatment of COVID-19.
-
UK Scientists Trial Instant Immunity Antibody Drug Treatment For Covid
Scientists in the UK have begun trials of innovative antibody drug treatments that they hope could provide instant protection against COVID-19.
-
WHO-Led Covid Drug Scheme Doubles Down On Antibodies, Steroids And Shuns Remdesivir
A World Health Organization-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids but is shunning Gilead's remdesivir blockbuster therapy, an internal document shows.
-
Lilly's COVID-19 Drug Could Be Ready For Use As Soon As September
Eli Lilly and Co could have a drug specifically designed to treat COVID-19 authorized for use as early as September if all goes well with either of two antibody therapies it is testing, its chief scientist told Reuters on Wednesday.
-
A New Drug Can Offer Relief To Migraine Sufferers; Some Amazing Home Remedies Can Also Help
Migraine, a type of headache disorder that is distinguished from tension headaches by its pain, frequency, and the nausea and sensitivities Lipsitz endured, affects 10 percent of the world population and 29.5 million Americans, the majority of them women.
-
Can Antibodies From Camels Help Develop Dengue Vaccines? Researchers From Mohali Reveal
Researchers from Indian Institute of Science Education and Research (IISER) Mohali have discovered that unique antibodies from camels may help neutralise the dengue virus. Scientists say these tiny "nanobodies" could pave the way for future dengue tr
-
Top Scientific Discoveries Of 2025: A Year of Quantum Leaps And Cosmic Revelations
Here's a look at scientific discoveries and breakthroughs that made headlines in 2025, spanning space, biology, ecology, and fundamental physics.
-
2 New Medicines For Covid Treatment Get WHO Approval
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
-
Delhi's LNJP Hospital Begins Free Antibody Cocktail Therapy For Covid Patients
The Monoclonal Antibody Cocktail used to treat mild to moderate "high risk" Covid patients is now available at Delhi's Lok Nayak Jai Prakash Narayan Hospital (LNJP) for free.
-
Antibody Cocktail Used In Covid Treatment Gets Emergency Use Approval
Drug firm Roche India on Wednesday said it has received Emergency Use Authorisation (EUA) from the Central Drugs Standards Control Organisation (CDSCO) for Roche's investigational antibody cocktail used in the treatment of COVID-19.
-
UK Scientists Trial Instant Immunity Antibody Drug Treatment For Covid
Scientists in the UK have begun trials of innovative antibody drug treatments that they hope could provide instant protection against COVID-19.
-
WHO-Led Covid Drug Scheme Doubles Down On Antibodies, Steroids And Shuns Remdesivir
A World Health Organization-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids but is shunning Gilead's remdesivir blockbuster therapy, an internal document shows.
-
Lilly's COVID-19 Drug Could Be Ready For Use As Soon As September
Eli Lilly and Co could have a drug specifically designed to treat COVID-19 authorized for use as early as September if all goes well with either of two antibody therapies it is testing, its chief scientist told Reuters on Wednesday.
-
A New Drug Can Offer Relief To Migraine Sufferers; Some Amazing Home Remedies Can Also Help
Migraine, a type of headache disorder that is distinguished from tension headaches by its pain, frequency, and the nausea and sensitivities Lipsitz endured, affects 10 percent of the world population and 29.5 million Americans, the majority of them women.
